Streetbeat News

ZJYL

Jin Medical International Ltd.

https://www.zhjmedical.com

Industry

Medical - Instruments & Supplies

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.

Open

1.96

Mkt cap

286M

Volume

278K

High

1.99

P/E Ratio

91.50

52-wk high

25.49

Low

1.79

Div yield

N/A

52-wk low

0.44

The article highlights the pre-market movements of 12 health care stocks on Friday. Notable gainers include Cue Health (HLTH), Innovative Eyewear (LUCY), SCWorx (WORX), Arcus Biosciences (RCUS), Biora Therapeutics (BIOR), and Jin Medical International (ZJYL). Significant losers include Verastem (VSTM), Sensei Biotherapeutics (SNSE), Genelux (GNLX), Summit Therapeutics (SMMT), Akari Therapeutics (AKTX), and Akso Health Group (AHG).

Portfolio Pulse from Benzinga Insights

May 24, 2024 | 12:07 pm

The article highlights the performance of 12 health care stocks during Monday's after-market session. Larimar Therapeutics (LRMR) saw the highest gain with a 23.6% increase, while NovaBay Pharmaceuticals (NBY) experienced the largest decline, falling by 9.9%. The article also mentions earnings reports for several companies.

Portfolio Pulse from Benzinga Insights

May 20, 2024 | 8:31 pm

Jin Medical International has regained compliance with Nasdaq's listing rule 5250(c) concerning the filing of its annual report, as per an SEC filing. This development indicates that the company has addressed previous concerns regarding its financial reporting obligations.

Portfolio Pulse from Benzinga Newsdesk

May 14, 2024 | 8:26 pm

Vaxxinity, Inc. announced its intention to voluntarily delist and deregister its Class A common stock, causing a sharp decline in its shares by around 55%. Other stocks experienced significant movements, with Matterport, Inc. seeing a jump due to an acquisition announcement by CoStar Group, and various companies reporting gains due to positive developments such as USDA approvals, IPO pricing, and compliance regains. Conversely, several companies faced declines due to negative news such as wind-down activities, delisting determinations, and price reductions.

Portfolio Pulse from Avi Kapoor

April 22, 2024 | 5:26 pm

In Friday's intraday session, several healthcare stocks experienced significant movements. Notably, Better Therapeutics (BTTX) surged by 65.4%, while SELLAS Life Sciences Gr (SLS) dropped by 28.7%. Other notable gainers include Carmell (CTCX) and P3 Health Partners (PIII), with increases of 38.52% and 38.23% respectively. On the losing end, Immuneering (IMRX) and Lucy Scientific Discovery (LSDI) saw declines of 28.45% and 25.64%. These movements reflect the volatile nature of healthcare stocks in the market.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 5:31 pm

In Friday's intraday session, several healthcare stocks experienced significant movements. Psyence Biomedical led the gainers with a 137.8% increase, while Amylyx Pharma saw the largest decline among the losers, dropping 81.5%. Other notable movers included Ainos, Mira Pharmaceuticals, and Joint, with substantial gains, and Immuron, Jin Medical International, and eFFECTOR Therapeutics among the losers.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 5:31 pm

Jin Medical International has successfully regained compliance with Nasdaq's listing requirements. This development is crucial for the company's continued listing on the exchange.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 2:31 pm

Bitdeer Technologies Group's shares surged 10.2% after reporting positive Q4 financial results and successful testing of its Bitcoin mining chip, amidst a general rise in Bitcoin prices. Other stocks also saw significant movements, with BitFuFu Inc. leading with a 107% jump following its Nasdaq listing. The session also highlighted FDA approvals, strategic approaches, and financial results as key drivers for stock movements. Conversely, companies like BioVie Inc. and JOANN Inc. faced declines due to public offering pricing and bankruptcy reports, respectively.

Portfolio Pulse from Avi Kapoor

March 04, 2024 | 6:29 pm

In Monday's intraday session, several healthcare stocks experienced significant movements. Ocean Biomedical (OCEA) led the gainers with a 55.0% increase, while BioVie (BIVI) saw the largest decrease among the losers, dropping 42.6%. Other notable movers included Jaguar Health (JAGX), Ainos (AIMD), and Renalytix (RNLX) with substantial gains, and Vivani Medical (VANI), First Wave BioPharma (FWBI), and FibroBiologics (FBLG) among the losers.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 5:34 pm

Jin Medical International (NYSE:ZJYL) has seen a significant decrease in short interest, with a 95.59% drop since the last report, indicating a potential shift in market sentiment towards the stock. The current short interest represents only 0.1% of the available shares for trading. This change suggests that investors may be becoming more bullish on ZJYL, contrasting with the average short interest of 9.26% among its peers.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 2:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.